3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
6
Neoplasms
3
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Lung Neoplasms
3
Carcinoma, Hepatocellular
3
Breast Neoplasms
3
Stomach Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Head and Neck Neoplasms
2
Disease
2
Colonic Neoplasms
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Vasculitis
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking Cessation
1
Small Cell Lung Carcinoma
1
Rectal Neoplasms
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Osteomyelitis
1
Nose Neoplasms
1
Myelodysplastic Syndromes
1
Multiple Pulmonary Nodules
1
Interventions
blinatumomab
6
Cyclophosphamide
5
Rituximab
4
Tacrolimus
3
ponatinib
2
fludarabine
2
denileukin diftitox
2
Vorinostat
2
Vincristine
2
Prednisone
2
Peripheral Blood Stem Cell Transplantation
2
Methotrexate
2
Everolimus
2
Etoposide
2
Doxorubicin
2
Darbepoetin alfa
2
Cytarabine
2
Busulfan
2
Brentuximab Vedotin
2
Antilymphocyte Serum
2
Alemtuzumab
2
tetulomab tetraxetan lu-177
1
ruxolitinib
1
pembrolizumab
1
pegaspargase
1
ibrutinib
1
ibritumomab tiuxetan
1
fludarabine phosphate
1
ferrous sulfate
1
ferric gluconate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Lymphoproliferative Disorders
×
Positron-Emission Tomography
×
Clear all
No trials found.